Similarly, our results demonstrated that a variety of inflammatory signaling pathways, such as IL2 STAT5 signaling and IL6 JAK STAT3 signaling, were upregulated in SCOS compared with OA (Figure 10F). The gene discussed is IL2; the disease is small cell osteogenic sarcoma.